Joint Formulary & PAD

Glibenclamide - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
SASH restricted to specialist monogenic clinic for use in specific diabetic subtypes (unlicensed drug - hospital only prescribing)

PAD Profile

ChemicalSubstance :
Glibenclamide
Indication :
Diabetes Mellitus
Group Name :
Keywords :
Sulfonylurea, Blood Glucose lowering drug, Type II, Sulphonylurea
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Glibenclamide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.

Committee Recommendations (1)

Not a preferred treatment option.
See guidelines below and associated documentation for further information